BioTechX Europe 2026 has ended. This guide stays up as the record of who was there. Next: BioTechX Europe 2027, Oct 11–13, 2027 in Basel

OP

Oncodesign Precision Medicine at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

Oncodesign Precision Medicine takes part in 2 sessions at BioTechX Europe 2026 in Basel. Its program centres on AI in drug discovery and development. The main focus is Nanocyclix, its platform that uses data and AI to design new kinase inhibitors, drugs that block a family of cell-signalling enzymes.

OrganizationBioTechX Europe 2026 Attendance
OP
Oncodesign Precision Medicine
Biotech
French biotech developing kinase inhibitors from its Nanocyclix macrocycle platform, using data-driven AI and machine learning.
Chair
Tue Oct 6
15:25
Chair's remarks
AI in Drug Discovery and Development
Talk
Thu Oct 8
11:30
The (R)evolution of Nanocyclix: A Data-Driven AI/ML Platform for Novel Kinase Inhibitors
AI in Drug Discovery and Development

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oncodesign Precision Medicine

Tell us what you sell and we’ll find the people at Oncodesign Precision Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BioTechX or its organizers. Submit a correction